ING Group’s Covetrus, Inc. Common Stock CVET Stock Holding History

ING Group’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-14,724	Closed	-$360K	–	796
2019 Q2	$360K	Buy	+14,724	New	+$424K	0.01%	613

Other funds holding CVET

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

ING Group's CVET Position: Q3 2019 in Review

ING Group sold out of Covetrus, Inc. Common Stock (CVET) in Q3 2019, closing a stake of 14,724 shares — an estimated $360K sold.

ING Group first reported a position in CVET in Q2 2019 and held it in 1 quarter. The position peaked at $360K in Q2 2019. 282 funds tracked by Wall St. Rank hold CVET as of Q3 2019.

ING Group reported no remaining Covetrus, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
ING Group sold 14,724 Covetrus, Inc. Common Stock shares in Q3 2019, an estimated $360K.
ING Group first reported a position in Covetrus, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
ING Group's Covetrus, Inc. Common Stock position peaked at $360K in Q2 2019.
282 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q3 2019.

Based on ING Group's 13F filing for Q3 2019, filed 8 Nov 2019.